These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36927350)

  • 1. Pemigatinib for the treatment of myeloid/lymphoid neoplasms with
    Freyer CW; Hughes ME; Carulli A; Bagg A; Hexner E
    Expert Rev Anticancer Ther; 2023 Apr; 23(4):351-359. PubMed ID: 36927350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report.
    Isaza AP; Quintero SC; González LPQ; Córdoba FEA; Olivar AFA; Ocaña JCB
    J Med Case Rep; 2023 Jan; 17(1):39. PubMed ID: 36698221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid/lymphoid neoplasms with FGFR1 rearrangement.
    Strati P; Tang G; Duose DY; Mallampati S; Luthra R; Patel KP; Hussaini M; Mirza AS; Komrokji RS; Oh S; Mascarenhas J; Najfeld V; Subbiah V; Kantarjian H; Garcia-Manero G; Verstovsek S; Daver N
    Leuk Lymphoma; 2018 Jul; 59(7):1672-1676. PubMed ID: 29119847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis.
    Chen M; Wang K; Cai X; Zhang X; Chao H; Chen S; Shen H; Wang Q; Zhang R
    Hematology; 2021 Dec; 26(1):153-159. PubMed ID: 33491601
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT.
    Hernández-Boluda JC; Pereira A; Zinger N; Gras L; Martino R; Nikolousis E; Finke J; Chinea A; Rambaldi A; Robin M; Saccardi R; Natale A; Snowden JA; Tsirigotis P; Vallejo C; Wulf G; Xicoy B; Russo D; Maertens J; Daguindau E; Lenhoff S; Hayden P; Czerw T; McLornan DP; Yakoub-Agha I
    Bone Marrow Transplant; 2022 Mar; 57(3):416-422. PubMed ID: 35066569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
    Kumar KR; Chen W; Koduru PR; Luu HS
    Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement.
    Umino K; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Hematology; 2018 Sep; 23(8):470-477. PubMed ID: 29486661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemic lineage switch in a t(8;22)(p11.2;q11.2)/
    Manur R; Sung PJ; Loren AW; Ritchie EK; Frank D; Bagg A; Geyer JT; Bogusz AM
    Leuk Lymphoma; 2020 Feb; 61(2):450-454. PubMed ID: 31524018
    [No Abstract]   [Full Text] [Related]  

  • 10. [The 8p11 myeloproliferative syndrome: a review of recent literature].
    Kirito K
    Rinsho Ketsueki; 2019; 60(9):1157-1165. PubMed ID: 31597839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and
    Yan Y; Qu S; Liu J; Li C; Yan X; Xu Z; Qin T; Jia Y; Pan L; Gao Q; Jiao M; Li B; Gale RP; Xiao Z
    Leuk Lymphoma; 2023 Sep; 64(9):1605-1610. PubMed ID: 37354441
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor.
    Verstovsek S; Subbiah V; Masarova L; Yin CC; Tang G; Manshouri T; Asatiani E; Daver NG
    Ann Oncol; 2018 Aug; 29(8):1880-1882. PubMed ID: 29767670
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia.
    Marinelli LM; Romain JT; Ehman W; Ortega V; Velagaleti G; Gibbons TF; Nazario-Toole A; Holmes AR
    Cancer Genet; 2023 Aug; 276-277():43-47. PubMed ID: 37480761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.
    Duckworth CB; Zhang L; Li S
    Int J Clin Exp Pathol; 2014; 7(2):801-7. PubMed ID: 24551307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare and potentially fatal - Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children.
    Berking AC; Flaadt T; Behrens YL; Yoshimi A; Leipold A; Holzer U; Lang P; Quintanilla-Martinez L; Schlegelberger B; Reiter A; Niemeyer C; Strahm B; Göhring G
    Cancer Genet; 2023 Apr; 272-273():29-34. PubMed ID: 36657267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemigatinib: First Approval.
    Hoy SM
    Drugs; 2020 Jun; 80(9):923-929. PubMed ID: 32472305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report.
    Chang K; Liu JH; Yu SC; Lin CW
    Hum Pathol; 2018 Apr; 74():114-121. PubMed ID: 29107667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
    Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
    Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
    Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid neoplasms with eosinophilia.
    Reiter A; Gotlib J
    Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.